Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

I think it's an educated guess based on the finding that Prurisol is more effective in moderate to severe psoriasis in the sub-population analysis.

That leads to the question(s), was some beneficial effect noted in the Prurisol PII trial in patients who exhibited both psoriasis and eczema, or is CTIX making an educated guess that Prurisol's effective treatment range extends to skin conditions beyond psoriasis?